| Title : Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit - Hoilund-Carlsen_2024_Ageing.Res.Rev__102348 |
| Author(s) : Hoilund-Carlsen PF , Alavi A , Barrio JR , Castellani RJ , Costa T , Herrup K , Kepp KP , Neve RL , Perry G , Revheim ME , Robakis NK , Sensi SL , Vissel B |
| Ref : Ageing Res Rev , :102348 , 2024 |
| Abstract : |
| PubMedSearch : Hoilund-Carlsen_2024_Ageing.Res.Rev__102348 |
| PubMedID: 38830549 |
| Title : Current approaches in the treatment of Alzheimer's disease - Shah_2008_Biomed.Pharmacother_62_199 |
| Author(s) : Shah RS , Lee HG , Xiongwei Z , Perry G , Smith MA , Castellani RJ |
| Ref : Biomed Pharmacother , 62 :199 , 2008 |
| Abstract : |
| PubMedSearch : Shah_2008_Biomed.Pharmacother_62_199 |
| PubMedID: 18407457 |